Carterra Brochure: Disruptive Drug Discovery Platforms for Screening and Characterization

Disruptive Technology for Screening and Characterization

The LSA and LSA^XT are the only fully integrated, high-throughput screening and characterization platforms on the market. The systems combine patented flow printing microfluidics with surface plasmon resonance (SPR) detection to deliver high-throughput kinetic and epitope analysis workflows that support state-of-the-art mAb discovery programs.

Unique fluidics integrate both 96-Channel Printhead and Single Flow Cell modes with high-throughput SPR
Up to 384 reaction spots + 48 reference spots per array
Supports capture formats and standard amine coupling

To download the rest of the brochure, please fill out the short form below. Thank you.

First Name*
Last Name*
Email*
Company*
Country*
State*
Zip Code*
Province
The information you provide will be used in accordance with the terms of our privacy policy.